Soleus Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-33,000
| Closed | -$4.24M | – | 100 |
|
|
2023
Q2 | $4.24M | Buy |
+33,000
| New | +$4.24M | 0.47% | 53 |
|
|
2023
Q1 | – | Sell |
-40,000
| Closed | -$4.53M | – | 81 |
|
|
2022
Q4 | $4.53M | Buy |
40,000
+16,164
| +68% | +$1.83M | 0.65% | 42 |
|
|
2022
Q3 | $1.92M | Sell |
23,836
-23,400
| -50% | -$1.88M | 0.26% | 57 |
|
|
2022
Q2 | $3.52M | Buy |
47,236
+800
| +2% | +$59.6K | 0.55% | 51 |
|
|
2022
Q1 | $5.94M | Buy |
46,436
+15,400
| +50% | +$1.97M | 0.77% | 37 |
|
|
2021
Q4 | $4.17M | Buy |
+31,036
| New | +$4.17M | 0.42% | 40 |
|
|
2021
Q3 | – | Sell |
-23,536
| Closed | -$2.51M | – | 74 |
|
|
2021
Q2 | $2.51M | Sell |
23,536
-4,204
| -15% | -$449K | 0.39% | 45 |
|
|
2021
Q1 | $2.49M | Sell |
27,740
-4,920
| -15% | -$442K | 0.45% | 44 |
|
|
2020
Q4 | $3.02M | Buy |
32,660
+2,328
| +8% | +$215K | 0.4% | 26 |
|
|
2020
Q3 | $3.13M | Sell |
30,332
-7,868
| -21% | -$811K | 1.66% | 25 |
|
|
2020
Q2 | $3.87M | Sell |
38,200
-15,600
| -29% | -$1.58M | 2.21% | 14 |
|
|
2020
Q1 | $3.62M | Sell |
53,800
-16,600
| -24% | -$1.12M | 4.21% | 8 |
|
|
2019
Q4 | $3.85M | Buy |
+70,400
| New | +$3.85M | 3.71% | 7 |
|